Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa
Main Authors: | Ivor Langley, Hsien-Ho Lin, S Bertel Squire |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-02-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X14703705 |
Similar Items
-
Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa
by: Keertan Dheda, et al.
Published: (2014-10-01) -
Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach
by: Ivor Langley, MSc, et al.
Published: (2014-10-01) -
The impact and cost of scaling up GeneXpert MTB/RIF in South Africa.
by: Gesine Meyer-Rath, et al.
Published: (2012-01-01) -
Клиническая эффективность теста Xpert MTB/RIF
Published: (2015-07-01) -
Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
by: Hou-He Li, et al.
Published: (2020-01-01)